Live Breaking News & Updates on Bard Peripheral Vascular
Stay updated with breaking news from Bard peripheral vascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VOYAGER-PAD finds no excess mortality or amputation risk with paclitaxel-coated devices When a 2018 meta-analysis of 28 trials reported "a significant relationship" between exposure to paclitaxel via a drug-eluting stent used to treat peripheral artery disease (PAD) and excess mortality, the FDA responded by first issuing a warning letter, followed by a second letter urging ....